Heart fat scans could unlock new heart failure treatments
NCT ID NCT07178145
First seen Jun 27, 2026 · Last updated Aug 12, 2026 · Updated 2 times
Summary
This study uses advanced MRI to measure the fat around the heart in people with a type of heart failure called HFpEF. Researchers want to see if the fat's composition, not just its amount, is linked to disease severity. They will also test if a diabetes drug called semaglutide changes this fat in a way that improves heart function. About 192 adults aged 18-90 with HFpEF risk factors will participate.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPICARDIAL ADIPOSE TISSUE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Virginia
RECRUITINGCharlottesville, Virginia, 22903, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Heart failure hope: gut bacteria and drug combo tested in seniors
- Preeclampsia's hidden heart risk: can exercise testing catch it early?
- Flozins under the microscope: can they protect heart and kidneys in High-Risk patients?
- New heart failure drug shows promise in early trial
- Gout drug allopurinol may boost heart function in african americans with resistant hypertension
- New device aims to unclog the Heart's drain for stubborn heart failure patients